

Synopsys vs Marvell
Leading provider of software and tools for chip design vs Chip designer for data centers and cloud networks. Which is the better buy for your portfolio in August 2026? Plain-English answer below.
Synopsys sells the software tools that chip designers use to create semiconductors, sitting upstream of the entire industry as the picks-and-shovels provider every fabless company needs, while Marvell designs custom and standard chips for data center, carrier infrastructure, and enterprise networking markets. Both companies are benefiting from the AI-driven semiconductor buildout, but Synopsys captures value through software licensing and Marvell through silicon design wins. The Synopsys vs Marvell comparison reveals two distinct positions in the semiconductor value chain and how each company monetizes the explosive demand for custom chip design.
Synopsys sells the software tools that chip designers use to create semiconductors, sitting upstream of the entire industry as the picks-and-shovels provider every fabless company needs, while Marvell...
Why It’s Moving

Synopsys stays in focus as strong earnings and upbeat analyst calls keep upside expectations elevated.
- Analysts remain broadly constructive on Synopsys, with consensus targets in the mid-$500s implying roughly low-30% upside versus recent trading levels, which has kept the stock on investors’ watchlists despite a mixed near-term setup.
- The latest earnings backdrop is supportive: Synopsys’ Q2 results came in above expectations, and management lifted full-year revenue guidance, signaling that demand for design automation and IP tools is still holding up.
- Recent analyst actions have reinforced the bullish tone, with firms reiterating Buy ratings and modestly raising targets after the company’s updated outlook, suggesting Wall Street sees continued execution rather than a short-term catalyst shock.

Marvell is moving on AI demand hopes and shifting analyst expectations ahead of the next earnings catalyst.
- Analyst sentiment remains constructive, with multiple firms keeping buy-equivalent ratings on Marvell and several recent target increases, suggesting expectations are still anchored to AI and data-center demand rather than a short-term turnaround story.
- The stock is still being traded more on forward-looking earnings expectations than on fresh company-specific news in the last week, which means every update to guidance or outlook can quickly reprice the shares.
- Broader semiconductor optimism is supporting the setup, but the range of published price targets remains wide, signaling that investors are still debating how much of Marvell’s AI growth is already reflected in the stock.

Synopsys stays in focus as strong earnings and upbeat analyst calls keep upside expectations elevated.
- Analysts remain broadly constructive on Synopsys, with consensus targets in the mid-$500s implying roughly low-30% upside versus recent trading levels, which has kept the stock on investors’ watchlists despite a mixed near-term setup.
- The latest earnings backdrop is supportive: Synopsys’ Q2 results came in above expectations, and management lifted full-year revenue guidance, signaling that demand for design automation and IP tools is still holding up.
- Recent analyst actions have reinforced the bullish tone, with firms reiterating Buy ratings and modestly raising targets after the company’s updated outlook, suggesting Wall Street sees continued execution rather than a short-term catalyst shock.

Marvell is moving on AI demand hopes and shifting analyst expectations ahead of the next earnings catalyst.
- Analyst sentiment remains constructive, with multiple firms keeping buy-equivalent ratings on Marvell and several recent target increases, suggesting expectations are still anchored to AI and data-center demand rather than a short-term turnaround story.
- The stock is still being traded more on forward-looking earnings expectations than on fresh company-specific news in the last week, which means every update to guidance or outlook can quickly reprice the shares.
- Broader semiconductor optimism is supporting the setup, but the range of published price targets remains wide, signaling that investors are still debating how much of Marvell’s AI growth is already reflected in the stock.
Investment Analysis

Synopsys
SNPS
Pros
- Synopsys holds a dominant position in the electronic design automation (EDA) market with near-100% customer retention and a strong recurring subscription revenue base.
- The company operates the largest semiconductor intellectual property licensing business, deeply embedding its products in the chip design ecosystem.
- Analyst consensus and forecasts suggest potential stock price appreciation driven by AI-driven software innovation and semiconductor market demand recovery.
Considerations
- U.S.-China trade tensions and export restrictions have materially impacted Synopsys’ China operations, leading to earnings misses and lowered guidance recently.
- Integration risks and short-term margin pressures are elevated due to the large acquisition of Ansys, which has also increased operating cost burdens in 2025.
- Competition from Cadence Design Systems remains strong, with Cadence frequently outperforming in operating margins and innovation, challenging Synopsys’ market share.

Marvell
MRVL
Pros
- Marvell Technology is well positioned in the semiconductor space with exposure to growth end markets such as data infrastructure and 5G, driving long-term demand.
- The company maintains a focus on expanding product offerings in high-growth segments like cloud networking and storage solutions.
- Recent financial performance shows solid revenue growth and improving operational efficiency, supporting potential profitability enhancement.
Considerations
- Marvell’s stock currently trades at elevated risk levels with sentiment and analyst scores indicating cautious outlook and higher volatility in the near term.
- The semiconductor industry's cyclicality exposes Marvell to economic downturn risks and fluctuations in capital investment cycles impacting demand.
- Competition from established and emerging semiconductor vendors could pressure Marvell’s market share and margins in its core segments.
Synopsys (SNPS) Next Earnings Date
Synopsys has not formally confirmed its next earnings date, but the market consensus points to September 8, 2026. That release would cover fiscal Q3 2026 results. Some calendars show a broader expected window in mid-to-late August, so the exact date may still shift.
Marvell (MRVL) Next Earnings Date
Marvell’s next earnings date is expected around August 27, 2026, though the company has not formally confirmed it yet. The release will cover fiscal Q2 2027 results, based on its current reporting cycle. If management follows its recent pattern, the announcement would likely come in the last week of August.
Synopsys (SNPS) Next Earnings Date
Synopsys has not formally confirmed its next earnings date, but the market consensus points to September 8, 2026. That release would cover fiscal Q3 2026 results. Some calendars show a broader expected window in mid-to-late August, so the exact date may still shift.
Marvell (MRVL) Next Earnings Date
Marvell’s next earnings date is expected around August 27, 2026, though the company has not formally confirmed it yet. The release will cover fiscal Q2 2027 results, based on its current reporting cycle. If management follows its recent pattern, the announcement would likely come in the last week of August.
Buy SNPS or MRVL in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


